Summit Partners Public Asset Management, LLC Sarepta Therapeutics, Inc. Call Options Transaction History

Summit Partners Public Asset Management, LLC

$2.28 Billion
Q2 2024

Call Options

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $2.05 Million - $2.47 Million	-20,000 Reduced 40.0%	30,000 $3.64 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $5.32 Million - $7.86 Million	50,000 New	50,000 $5.73 Million

Others Institutions Holding SRPT

# of Institutions

557

Shares Held

85.6M

Call Options Held

3.67M

Put Options Held

1.75M

Black Rock Inc. New York, NY

10.3M
Shares

$1.3 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

9.04M
Shares

$1.14 Billion
0.03% of portfolio
Capital International Investors Los Angeles, CA

4.32M
Shares

$544 Million
0.14% of portfolio
State Street Corp Boston, MA

4.14M
Shares

$522 Million
0.03% of portfolio
Janus Henderson Group PLC London, X0

3.82M
Shares

$481 Million
0.33% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.

Account